John P Pierce1. 1. Cancer Prevention and Control Program, MooresUCSD Cancer Center, University of California, SanDiego, La Jolla, California 92093-0901, USA. jppierce@ucsd.edu
Abstract
PURPOSE OF REVIEW: To clarify the role of dietary pattern on prognosis in breast cancer survivors. RECENT FINDINGS: Observational trials show mixed results that do not strongly support an independent role for dietary pattern in prognosis. Women's Intervention Nutrition Study and Women's Healthy Eating and Living (WHEL) are two large randomized controlled trials that address this question. The interventions from both studies achieved significant reductions in energy from fat, and the WHEL Study achieved large increases in vegetables, fruit and fiber. Women's Intervention Nutrition Study examined postmenopausal women only and reported a not-quite-significant improved prognosis for women in the intervention group, with the benefit focused on ipsilateral localized recurrences, but little improvement in the more important distal recurrences. This review considers only WHEL postmenopausal women to aid a direct comparison with Women's Intervention Nutrition Study. The WHEL Study reported a convincing lack of association between diet and prognosis. However, a secondary analysis suggests that the dietary intervention reduced distal recurrences among the subgroup without hot flashes at baseline. SUMMARY: There is no convincing evidence that changing dietary pattern following breast cancer diagnosis will improve prognosis for most women with early stage breast cancer. However, it would appear to be important for some subgroups. Further investigation of mechanisms for such selective action is needed.
PURPOSE OF REVIEW: To clarify the role of dietary pattern on prognosis in breast cancer survivors. RECENT FINDINGS: Observational trials show mixed results that do not strongly support an independent role for dietary pattern in prognosis. Women's Intervention Nutrition Study and Women's Healthy Eating and Living (WHEL) are two large randomized controlled trials that address this question. The interventions from both studies achieved significant reductions in energy from fat, and the WHEL Study achieved large increases in vegetables, fruit and fiber. Women's Intervention Nutrition Study examined postmenopausal women only and reported a not-quite-significant improved prognosis for women in the intervention group, with the benefit focused on ipsilateral localized recurrences, but little improvement in the more important distal recurrences. This review considers only WHEL postmenopausal women to aid a direct comparison with Women's Intervention Nutrition Study. The WHEL Study reported a convincing lack of association between diet and prognosis. However, a secondary analysis suggests that the dietary intervention reduced distal recurrences among the subgroup without hot flashes at baseline. SUMMARY: There is no convincing evidence that changing dietary pattern following breast cancer diagnosis will improve prognosis for most women with early stage breast cancer. However, it would appear to be important for some subgroups. Further investigation of mechanisms for such selective action is needed.
Authors: P Toniolo; A L Van Kappel; A Akhmedkhanov; P Ferrari; I Kato; R E Shore; E Riboli Journal: Am J Epidemiol Date: 2001-06-15 Impact factor: 4.897
Authors: S A Smith-Warner; D Spiegelman; S S Yaun; H O Adami; W L Beeson; P A van den Brandt; A R Folsom; G E Fraser; J L Freudenheim; R A Goldbohm; S Graham; A B Miller; J D Potter; T E Rohan; F E Speizer; P Toniolo; W C Willett; A Wolk; A Zeleniuch-Jacquotte; D J Hunter Journal: JAMA Date: 2001-02-14 Impact factor: 56.272
Authors: Cheryl L Rock; Shirley W Flatt; Cynthia A Thomson; Marcia L Stefanick; Vicky A Newman; Lovell A Jones; Loki Natarajan; Cheryl Ritenbaugh; Kathryn A Hollenbach; John P Pierce; R Jeffrey Chang Journal: J Clin Oncol Date: 2004-06-15 Impact factor: 44.544
Authors: Sheila A Bingham; Robert Luben; Ailsa Welch; Nicholas Wareham; Kay-Tee Khaw; Nicholas Day Journal: Lancet Date: 2003-07-19 Impact factor: 79.321
Authors: Joanne E Mortimer; Shirley W Flatt; Barbara A Parker; Ellen B Gold; Linda Wasserman; Loki Natarajan; John P Pierce Journal: Breast Cancer Res Treat Date: 2007-05-31 Impact factor: 4.872
Authors: John P Pierce; Susan Faerber; Fred A Wright; Cheryl L Rock; Vicky Newman; Shirley W Flatt; Sheila Kealey; Vicky E Jones; Bette J Caan; Ellen B Gold; Mary Haan; Kathryn A Hollenbach; Lovell Jones; James R Marshall; Cheryl Ritenbaugh; Marcia L Stefanick; Cynthia Thomson; Linda Wasserman; Loki Natarajan; Ronald G Thomas; Elizabeth A Gilpin Journal: Control Clin Trials Date: 2002-12
Authors: Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith Journal: Cochrane Database Syst Rev Date: 2012-05-16
Authors: H Irene Su; Laura Y Sue; Shirley W Flatt; Loki Natarajan; Ruth E Patterson; John P Pierce Journal: J Womens Health (Larchmt) Date: 2013-10-10 Impact factor: 2.681
Authors: Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger Journal: Cancer Prev Res (Phila) Date: 2012-10-03
Authors: Brian N Fink; Jeffrey G Weiner; Timothy R Jordan; Amy J Thompson; Timothy C Salvage; Mina Coman; Joyce Balls-Berry Journal: Breast Cancer (Auckl) Date: 2010-11-18